Invention Grant
- Patent Title: 7-piperidinoalkyl-3, 4-Dihydroquinolone derivative
- Patent Title (中): 7-哌啶子基烷基-3,4-二氢喹诺酮衍生物
-
Application No.: US13122281Application Date: 2009-09-30
-
Publication No.: US08461182B2Publication Date: 2013-06-11
- Inventor: Kosuke Kanuma , Naoki Miyakoshi , Madoka Kawamura , Tsuyoshi Shibata
- Applicant: Kosuke Kanuma , Naoki Miyakoshi , Madoka Kawamura , Tsuyoshi Shibata
- Applicant Address: JP Tokyo
- Assignee: Taisho Pharmaceutical Co., Ltd.
- Current Assignee: Taisho Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2008-257072 20081002
- International Application: PCT/JP2009/067441 WO 20090930
- International Announcement: WO2010/038901 WO 20100408
- Main IPC: A61K31/04
- IPC: A61K31/04 ; C07D215/38

Abstract:
PROBLEMTo provide a novel compound, a pharmaceutically acceptable salt or a hydrate thereof useful for preventing or treating for depression, anxiety disorders (such as generalized anxiety disorder, posttraumatic stress disorder, panic disorder, obsessive-compulsive disorder or social anxiety disorder), attention deficit disorder, mania, manic-depressive illness, schizophrenia, mood disorders, stress, sleep disorders, attacks, memory impairment, cognitive impairment, dementia, amnesia, delirium, obesity, eating disorder, appetite disorder, hyperphagia, bulimia, cibophobia, diabetes, cardiovascular diseases, hypertension, dyslipidemia, myocardial infarction, movement disorder (such as Parkinson's disease, epilepsy, convulsion or tremor), drug abuse, drug addiction or sexual dysfunction, based on a melanin-concentrating hormone receptor (MCH receptor) antagonistic action.SOLUTIONA compound, a pharmaceutically acceptable salt or a hydrate thereof represented by the formula (I).
Public/Granted literature
- US20110178304A1 7-PIPERIDINOALKYL-3, 4-DIHYDROQUINOLONE DERIVATIVE Public/Granted day:2011-07-21
Information query